These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3337613)

  • 21. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers.
    Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F
    Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
    Schildkraut JJ
    Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
    [No Abstract]   [Full Text] [Related]  

  • 23. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.
    Linnoila M; Karoum F; Rosenthal N; Potter WZ
    Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates.
    Linnoila M; Oliver J; Adinoff B; Potter WZ
    Arch Gen Psychiatry; 1988 Aug; 45(8):701-4. PubMed ID: 3395200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 Apr; 139(4):471-5. PubMed ID: 7065292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings.
    Muscettola G; Potter WZ; Pickar D; Goodwin FK
    Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients.
    Joseph MH; Baker HF; Johnstone EC; Crow TJ
    Psychopharmacology (Berl); 1976 Dec; 51(1):47-51. PubMed ID: 827775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamine metabolites in spinal cord injury.
    Harvey RF; Fullerton DT; Carlson IH; Klein MH; Howell T
    Arch Phys Med Rehabil; 1982 Sep; 63(9):419-22. PubMed ID: 7115040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A; Pickar D; Linnoila M; Chrousos GP; Gold PW
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interconversion of O-methylated norepinephrine metabolites in humans.
    Brown RT; Polinsky RJ; Kopin IJ
    J Lab Clin Med; 1987 Jul; 110(1):119-24. PubMed ID: 3598334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression.
    Janicak PG; Davis JM; Chan C; Altman E; Hedeker D
    Am J Psychiatry; 1986 Nov; 143(11):1398-402. PubMed ID: 3777227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
    Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ
    Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive symptom patterns and urinary MHPG excretion.
    Agren H
    Psychiatry Res; 1982 Apr; 6(2):185-96. PubMed ID: 6953458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfate and glucuronide conjugates of 3-methoxy-4-hydroxyphenylglycol (MHPG) in urine of depressed patients: central and peripheral influences.
    Peyrin L; Pequignot JM; Chauplannaz G; Laurent B; Aimard G
    J Neural Transm; 1985; 63(3-4):255-69. PubMed ID: 4067598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary-free cortisol in depressed patients and controls: relationship to urinary indices of noradrenergic function.
    Roy A; Linnoila M; Karoum F; Pickar D
    Psychol Med; 1988 Feb; 18(1):93-8. PubMed ID: 3363046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of moderate exercise on urinary MHPG in depressed patients.
    Beckmann H; Ebert MH; Post R; Goodwin FK
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):351-6. PubMed ID: 504341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled exercise elevates plasma but not urinary MHPG and VMA.
    Tang SW; Stancer HC; Takahashi S; Shephard RJ; Warsh JJ
    Psychiatry Res; 1981 Feb; 4(1):13-20. PubMed ID: 6938998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients.
    Filser JG; Spira J; Fischer M; Gattaz WF; Müller WE
    J Psychiatr Res; 1988; 22(3):171-81. PubMed ID: 2852249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of circadian rhythmicities of urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) and vanilmandelic acid (VMA) in man during cold exposure.
    Cymerman A; Francesconi RF
    Life Sci; 1975 Jan; 16(2):225-36. PubMed ID: 1110601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.